272
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer

, , ORCID Icon, , &
Pages 25-35 | Published online: 06 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jundong Lin, Yangjia Zhuo, Yixun Zhang, Ren Liu & Weide Zhong. (2023) Molecular predictors of metastasis in patients with prostate cancer. Expert Review of Molecular Diagnostics 23:3, pages 199-215.
Read now

Articles from other publishers (35)

Bingbing Yang, Xiaoqi Xin, Xiaoqing Cao, Lubanga Nasifu, Zhenlin Nie & Bangshun He. (2024) The diagnostic and prognostic value of exosomal microRNAs in lung cancer: a systematic review. Clinical and Translational Oncology.
Crossref
Elvan Bakar, Zeynep Erim & Nebiye Pelin Türker. 2023. Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective. Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective 117 165 .
Murad Alahdal, Roshane A. Perera, Marcio Covas Moschovas, Vipul Patel & Ranjan J. Perera. (2023) Current advances of liquid biopsies in prostate cancer: Molecular biomarkers. Molecular Therapy - Oncolytics 30, pages 27-38.
Crossref
Junbeom Kim, Mina Kim, Ji Yoon Kang, Ki Wan Bong & Nakwon Choi. (2023) The Detection of Urinary Exosomal miRNAs for Cancer Diagnostics and Prognostics. BioChip Journal 17:3, pages 308-317.
Crossref
You Zhou, Yuqing Dong, Aixue Zhang, Jibin Wu & Qiang Sun. (2023) The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Afroditi Ziogou, Alexios Giannakodimos & Ilias Giannakodimos. (2023) The Role of Urinary miRNAs in the Diagnosis, Management and Follow- Up of Prostatic Cancer. MicroRNA 12:2, pages 83-86.
Crossref
Jeevan Larson, Mehmet Ozgun Ozen, Manish Kohli, Demir Akin & Utkan Demirci. (2023) Systematic Analysis of Tissue‐Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer. Advanced Biology 7:7.
Crossref
Yang Hao, Feifan Zhang, Yan Ma, Yage Luo, Yongyong Zhang, Ning Yang, Man Liu, Hongjian Liu & Jitian Li. (2023) Potential biomarkers for the early detection of bone metastases. Frontiers in Oncology 13.
Crossref
Jaya Aseervatham. (2023) Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. Biology 12:5, pages 710.
Crossref
Sougata Ghosh Chowdhury, Rachayeeta Ray & Parimal Karmakar. (2022) Exosomal miRNAs—a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer. Functional & Integrative Genomics 23:1.
Crossref
Tong Wu, Ying Liu, Nasra Mohamoud Ali, Bin Zhang & Xiaonan Cui. (2023) Effects of Exosomes on Tumor Bioregulation and Diagnosis. ACS Omega 8:6, pages 5157-5168.
Crossref
Fatima Ghamlouche, Amani Yehya, Yousef Zeid, Hiam Fakhereddine, Jhonny Fawaz, Yen-Nien Liu, Mohamed Al-Sayegh & Wassim Abou-Kheir. (2023) MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. Translational Oncology 28, pages 101613.
Crossref
Harley Robinson, Matthew J. Roberts, Robert A. Gardiner & Michelle M. Hill. (2023) Extracellular vesicles for precision medicine in prostate cancer – Is it ready for clinical translation?. Seminars in Cancer Biology 89, pages 18-29.
Crossref
Garima Jain, Parimal Das, Prashant Ranjan, Neha, Ferran Valderrama & Clara Cieza-Borrella. (2023) Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers. Frontiers in Genetics 14.
Crossref
Narjes Amiri, Paria Mohammadi, Atefeh Allahgholi, Farzaneh Salek & Elaheh Amini. (2023) The potential of sertoli cells (SCs) derived exosomes and its therapeutic efficacy in male reproductive disorders. Life Sciences 312, pages 121251.
Crossref
Onur Obut, Pınar Akbaba, Mehmet Ali Balcı, Yakup Bakır & Vahap Eldem. 2023. Oncology: Genomics, Precision Medicine and Therapeutic Targets. Oncology: Genomics, Precision Medicine and Therapeutic Targets 39 76 .
K. Auxzilia Preethi, Sushmaa Chandralekha Selvakumar, Kehinde Ross, Selvaraj Jayaraman, Deusdedit Tusubira & Durairaj Sekar. (2022) Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer. Molecular Cancer 21:1.
Crossref
Ahmad Movahedpour, Seyyed Hossein Khatami, Neda Karami, Omid Vakili, Parisa Naeli, Zeinab Jamali, Zahra Shabaninejad, Khalil Tazik, Hamid Behrouj & Hassan Ghasemi. (2022) Exosomal noncoding RNAs in prostate cancer. Clinica Chimica Acta 537, pages 127-132.
Crossref
Rumiana Tenchov, Janet M. Sasso, Xinmei Wang, Wen-Shing Liaw, Chun-An Chen & Qiongqiong Angela Zhou. (2022) Exosomes─Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano 16:11, pages 17802-17846.
Crossref
Chunyan Zhang, Caifang Sun, Yabin Zhao, Qiwen Wang, Jianlin Guo, Bingyu Ye & Guoying Yu. (2022) Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021. International Journal of Molecular Sciences 23:19, pages 11389.
Crossref
Szeliski K, Drewa T & Pokrywczyńska M. (2022) Small extracellular vesicles as a multicomponent biomarker platform in urinary tract carcinomas. Frontiers in Molecular Biosciences 9.
Crossref
Jing Zhao, Juan Chen, Wei Zhu, Xiang‐ming Qi & Yong‐gui Wu. (2022) Exosomal miR ‐7002‐5p derived from highglucose‐induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b . The FASEB Journal 36:9.
Crossref
Ilias Giannakodimos. (2022) Urinary miRNAs as Diagnostic Biomarkers for Prostatic Cancer: Current Dilemmas and Novel Potential Role for a Digital Rectal Examination. Current Medicinal Chemistry 29:25, pages 4311-4313.
Crossref
Virinder Kaur Sarhadi & Gemma Armengol. (2022) Molecular Biomarkers in Cancer. Biomolecules 12:8, pages 1021.
Crossref
Jaroslav Juracek, Marie Madrzyk, Michal Stanik & Ondrej Slaby. (2022) Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update. Cancers 14:13, pages 3157.
Crossref
Xin Li & Lina Yang. (2022) Urinary exosomes: Emerging therapy delivery tools and biomarkers for urinary system diseases. Biomedicine & Pharmacotherapy 150, pages 113055.
Crossref
Safura Jokar, Inês A. Marques, Saeedeh Khazaei, Tania Martins-Marques, Henrique Girao, Mafalda Laranjo & Maria Filomena Botelho. (2022) The Footprint of Exosomes in the Radiation-Induced Bystander Effects. Bioengineering 9:6, pages 243.
Crossref
Manuel Ramirez-Garrastacho, Cristina Bajo-Santos, Aija Line, Elena S. Martens-Uzunova, Jesus Martinez de la Fuente, Maria Moros, Carolina Soekmadji, Kristin Austlid Tasken & Alicia Llorente. (2021) Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. British Journal of Cancer 126:3, pages 331-350.
Crossref
Manuel Ramirez-Garrastacho, Viktor Berge, Aija Linē & Alicia Llorente. (2021) Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. British Journal of Cancer 126:3, pages 492-501.
Crossref
Maija Puhka, Lisse Thierens, Daniel Nicorici, Tarja Forsman, Tuomas Mirtti, Taija af Hällström, Elina Serkkola & Antti Rannikko. (2022) Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression. Cancers 14:3, pages 532.
Crossref
Chantell Payton, Lisa Y. Pang, Mark Gray & David J. Argyle. (2021) Exosomes Derived from Radioresistant Breast Cancer Cells Promote Therapeutic Resistance in Naïve Recipient Cells. Journal of Personalized Medicine 11:12, pages 1310.
Crossref
Eva Slabáková, Zuzana Kahounová, Jiřina Procházková & Karel Souček. (2021) Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs. Non-Coding RNA 7:4, pages 75.
Crossref
Maria I. Mosquera-Heredia, Luis C. Morales, Oscar M. Vidal, Ernesto Barceló, Carlos Silvera-Redondo, Jorge I. Vélez & Pilar Garavito-Galofre. (2021) Exosomes: Potential Disease Biomarkers and New Therapeutic Targets. Biomedicines 9:8, pages 1061.
Crossref
Luis Martínez-González, Victor Sánchez-Conde, Jose González-Cabezuelo, Alba Antunez-Rodríguez, Eduardo Andrés-León, Inmaculada Robles-Fernandez, Jose Lorente, Fernando Vázquez-Alonso & María Alvarez-Cubero. (2021) Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer. Biomedicines 9:6, pages 646.
Crossref
Olaf Strømme, Kathleen A. Heck, Gaute Brede, Håvard T. Lindholm, Marit Otterlei & Carl-Jørgen Arum. (2021) Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors. Current Issues in Molecular Biology 43:1, pages 286-300.
Crossref